Japan Intellectual Property Rights: COMPOUNDS COMPRISING FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF

Japan, Jan. 20 -- 3B PHARMACEUTICALS GMBH has got intellectual property rights for 'COMPOUNDS COMPRISING FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF.' Other related details are as follows:

Application Number: JP,2024-221293

Category (FI): A61K33/32,C07K7/00,C07K1/16,A61K38/12,A61P35/00,A61K47/64,A61K33/24,A61K33/244,A61K33/34,A61K33/30,A61K33/18,A61K33/16,A61K33/245,C12M1/00@A,C07K7/06,A61K51/08,100,A61K51/08,200

Stage: Grant (IP right document published.)

Filing Date: Dec. 18, 2024

Publication Date: March 18, 2025

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.